Selective Peroxisome Proliferator–Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?

por Fruchart, Jean-Charles, Hermans, Michel P., Fruchart-Najib, Jamila
Publicado 2020

Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?

por Fruchart, Jean-Charles, Hermans, Michel P., Fruchart-Najib, Jamila, Kodama, Tatsuhiko
Publicado 2021

Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alc...

por Murakami, Kentaro, Sasaki, Yusuke, Asahiyama, Masato, Yano, Wataru, Takizawa, Toshiaki, Kamiya, Wakana, Matsumura, Yoshihiro, Anai, Motonobu, Osawa, Tsuyoshi, Fruchart, Jean-Charles, Fruchart-Najib, Jamila, Aburatani, Hiroyuki, Sakai, Juro, Kodama, Tatsuhiko, Tanaka, Toshiya
Publicado 2022